MARKET

PDEX

PDEX

Pro Dex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.16
-0.17
-0.51%
Opening 14:03 06/16 EDT
OPEN
33.20
PREV CLOSE
33.33
HIGH
34.48
LOW
33.02
VOLUME
7.43K
TURNOVER
--
52 WEEK HIGH
42.60
52 WEEK LOW
16.76
MARKET CAP
120.98M
P/E (TTM)
21.73
1D
5D
1M
3M
1Y
5Y
Pro-Dex, Inc. Discusses Record Third Quarter Sales and Aggressive Growth Strategy with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - June 3, 2021) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-fun...
Newsfile Corp · 06/03 15:19
Returns On Capital Are Showing Encouraging Signs At Pro-Dex (NASDAQ:PDEX)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Simply Wall St. · 05/28 09:30
70 Biggest Movers From Friday
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
Benzinga · 05/10 09:24
Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop
Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81.
Benzinga · 05/07 19:03
Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide
Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93.
Benzinga · 05/07 16:20
Regional Health Properties, Auris Medical leads healthcare gainers; ChemoCentryx, Orphazyme among major losers
Gainers: Regional Health Properties (RHE) +39%, Auris Medical (EARS) +26%, Clene (CLNN) +25%, Pro-Dex (PDEX) +20%, Epizyme (EPZM) +17%.Losers: ChemoCentryx (CCXI) -59%, Orphazyme (ORPH) -30%, F-star Therapeutics (FSTX) -21%, Aurinia Pharmaceuticals (AUPH) ...
Seekingalpha · 05/07 15:04
Pro-Dex EPS beats by $0.28, beats on revenue
Pro-Dex (PDEX): FQ3 GAAP EPS of $0.50 beats by $0.28.Revenue of $11.74M (+38.0% Y/Y) beats by $3.23M.Press Release
Seekingalpha · 05/06 21:16
Pro-Dex Q3 EPS $0.50 Up From $0.30 YoY, Sales $11.70M Up From $8.51M YoY
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.50 per share. This is a 66.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported $11.70 million in sales this
Benzinga · 05/06 20:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PDEX. Analyze the recent business situations of Pro Dex through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PDEX stock price target is 41.00 with a high estimate of 41.00 and a low estimate of 41.00.
EPS
Institutional Holdings
Institutions: 42
Institutional Holdings: 1.00M
% Owned: 27.54%
Shares Outstanding: 3.65M
TypeInstitutionsShares
Increased
7
52.63K
New
10
101.96K
Decreased
8
67.08K
Sold Out
7
85.47K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.42%
Healthcare Equipment & Supplies
-0.63%
Key Executives
Chairman/Independent Director
Nicholas Swenson
President/Chief Executive Officer/Chief Operating Officer/Director
Richard Van Kirk
Chief Financial Officer
Alisha Charlton
Director
Katrina Philp
Independent Director
Raymond Cabillot
Independent Director
William Farrell
Independent Director
David Hovda
No Data
  • All
  • Financials
  • Insiders
More
About PDEX
Pro-Dex, Inc. (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through three segments: Pro-Dex, OMS and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce. The OMS segment is engaged in providing multi-axis motion control applications. In addition to Pro-Dex, the names Micro Motors and Oregon Micro Systems are used for marketing purposes as brand names. The Company provides engineering consulting services, as well as quality and regulatory consulting services, to a range of industries through EDS.

Webull offers kinds of Pro-Dex Inc stock information, including NASDAQ:PDEX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDEX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PDEX stock methods without spending real money on the virtual paper trading platform.